MercoPress, en Español
Montevideo, November 21st 2024 - 19:51 UTC
Brazil's Fiocruz biomedical institute will seek approval for the Oxford University/AstraZeneca vaccine against COVID-19 with federal health regulator Anvisa on Jan. 15, one of the center's senior officials said on Monday.
Get our news on your inbox! Suscribe